In vivo performance of airway and lung ultrasound enhanced via inhalable contrast agents
The Journal of the Acoustical Society of America · 01.10.2025 · 158 (4_Supplement) · A107-A107
DOI: 10.1121/10.0040282 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of the Acoustical Society of America, erschienen am 01.10.2025. Verfasst von Andrew S. Weitz und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Airway mucus obstruction is a hallmark of cystic fibrosis (CF) and other muco-obstructive pulmonary diseases (MOPDs), yet clinical imaging tools for assessing mucociliary clearance (MCC) remain limited. To address this gap, we developed a muco-adhesive ultrasound contrast agent by incorporating 1,2-distearoyl-3-trimethylammonium-propane (TAP) onto standard microbubbles (MBs), enabling electrostatic binding to negatively charged mucins. In mice, we compared TAP-cationic MBs to standard MBs and lipid solution via tracheal instillation and contrast-enhanced ultrasound imaging. TAP-MBs produced comparable contrast-to-noise ratio (CNR) values to standard MBs (42.3 ± 8.4 dB vs 45.1 ± 11.9 dB), both of which significantly outperformed the lipid solution (11.9 ± 7.9 dB; p < 0.05). In a porcine model, we demonstrated proof-of-concept delivery of aerosolized TAP-MBs to distal airways, visualized as “tree-in-bud” patterns consistent with MB accumulation. Together, these findings establish the feasibility of both muco-adhesive MB contrast for enhancing airway ultrasound and its aerosolized delivery to small airways. This approach supports TAP-MBs as a non-ionizing repeatable method for assessing MCC and airway obstruction in MOPDs, while laying the groundwork for future therapeutic applications based on MB cavitation. Ultimately, this technique may provide a radiation-free strategy for monitoring respiratory health and guiding treatment in patients with mucus-associated airway disease.
Zitieren
APA
Weitz, A. S., Durham, P., Clapp, P., Hill, D., Tsuruta, J., Lee, Y., Dayton, P. A., & Caughey, M. (2025). In vivo performance of airway and lung ultrasound enhanced via inhalable contrast agents. The Journal of the Acoustical Society of America, 158(4_Supplement), A107-A107. https://doi.org/10.1121/10.0040282
Vancouver
Weitz AS, Durham P, Clapp P, Hill D, Tsuruta J, Lee Y, et al. In vivo performance of airway and lung ultrasound enhanced via inhalable contrast agents. The Journal of the Acoustical Society of America. 2025;158(4_Supplement):A107-A107. doi:10.1121/10.0040282
BibTeX
@article{Weitz2025,
author = {Weitz, Andrew S. and Durham, Phillip and Clapp, Phillip and Hill, David and Tsuruta, James and Lee, Yueh and Dayton, Paul A. and Caughey, Melissa},
title = {In vivo performance of airway and lung ultrasound enhanced via inhalable contrast agents},
journal = {The Journal of the Acoustical Society of America},
year = {2025},
volume = {158},
number = {4_Supplement},
pages = {A107--A107},
doi = {10.1121/10.0040282}
}
EUVIMED